-
Anti-TNFα therapy may help reduce risk of developing Parkinson’s disease
europeanpharmaceuticalreview
April 25, 2019
Mount Sinai shows the potential link between Parkinson’s disease and inflammatory bowel disease, suggests anti-TNFα therapy may reduce the risk of developing Parkinson’s…
-
CDC Provides Clarification of Opioid Prescribing Guideline
drugs
April 25, 2019
CDC Provides Clarification of Opioid Prescribing Guideline
-
Sanofi concludes option phase of rare disease alliance with Alnylam
pharmaceutical-technology
April 23, 2019
Sanofi concludes option phase of rare disease alliance with Alnylam.
-
Regeneron and Alnylam partner on eye and CNS disease therapies
pharmaceutical-technology
April 23, 2019
Regeneron and Alnylam partner on eye and CNS disease therapies.
-
Repurposing cancer drugs may lead to a new approach to treating TB
europeanpharmaceuticalreview
April 22, 2019
Promising experimental cancer chemotherapy drugs may help knock out another life-threatening disease: tuberculosis (TB)…
-
Aortic Valve Disease Does Its Damage Slowly
drugs
April 22, 2019
Aortic valve stenosis is a form of heart valve disease that can take many years to develop into a life-threatening problem, an expert says.
-
Study shows CRISPR could help treat lung disease in utero
pharmaceutical-technology
April 22, 2019
Study shows CRISPR could help treat lung disease in utero.
-
Direct anticoagulants associated with increased risk of bleeding
europeanpharmaceuticalreview
April 19, 2019
Results of a study suggest the need for caution in the prescription of direct oral anticoagulants for patients with chronic kidney disease, due to the risk of bleeding…
-
Benzodiazepines associated with an increased risk of Alzheimer’s disease
europeanpharmaceuticalreview
April 19, 2019
Current advice points to single or occasional use of the drug, and it is not recommended to be used for longer than four weeks…
-
Artificial intelligence improves diagnosis of lung disease: study
europeanpharmaceuticalreview
April 18, 2019
Diagnosing lung disease using AI was found to be accurate in twice as many cases as the diagnosis of pulmonologists…